| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 09/29/2011 | US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 09/29/2011 | US20110236505 Carbohydrate bar |
| 09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
| 09/29/2011 | CA2800248A1 Compounds to be used in the treatment of diseases based on the expression of toxic transcripts |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/28/2011 | EP2367555A2 Regenerating and enhancing development of muscle tissue |
| 09/28/2011 | EP1424330B1 Activator for peroxisome proliferator-responsive receptor delta |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | CN1646139B Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/28/2011 | CN102203255A RNA antagonists targeting HSP27 |
| 09/28/2011 | CN102199593A Method for linking sequences of interest |
| 09/28/2011 | CN102199081A 2-acetylaloeemodin and preparation method and application thereof |
| 09/27/2011 | US8026213 Methods for treating muscle diseases and disorders |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | CA2647206C N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use |
| 09/22/2011 | WO2011115184A1 Inhibitor of in vivo proteolysis |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | CN102190728A Novel humanized anti-CD20 monoclonal antibody |
| 09/21/2011 | CN102188661A Traditional Chinese medicine for removing arthralgia and preparation method thereof |
| 09/21/2011 | CN102188341A Massage oil with functions of expelling wind and clearing away cold |
| 09/21/2011 | CN101084009B Gh secretagogues and uses thereof |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021687 Modified release compositions of milnacipran |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | US20110224675 Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224234 Polymorph B of N--N-methyl-acetamide |
| 09/15/2011 | US20110224220 Substituted tricyclic derivatives |
| 09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224128 Methods and compositions for treatment of muscular dystrophy |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223203 Nanocluster compositions and methods |
| 09/15/2011 | US20110223190 Methods for the administration of FV and related compositions |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/14/2011 | EP1445314B1 Novel glutamic acid receptor and utilization thereof |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102180879A Polycrystalline type alpha acetic acid solvate of hypnotic |
| 09/14/2011 | CN102180780A Indenone derivative and applications thereof as developing agent and aggregation inhibitor of amyloid protein deposit and neurofibrillary tangle |
| 09/14/2011 | CN102178918A Externally applied Chinese medicine for treating sprain |
| 09/14/2011 | CN102178905A Chinese medicine body surface application therapeutic technology and Chinese medicine combinations |
| 09/14/2011 | CN102178670A Nitrate esters and their use for the treatment of muscle and muscle related diseases |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017596 Phosphonates useful as modulators of T-γ-9-δ-2 activity |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011108692A1 Agent for preventing muscular atrophy |
| 09/09/2011 | WO2011108487A1 Muscular atrophy inhibitor |
| 09/09/2011 | WO2011108009A2 Process for the preparation of fampridine |
| 09/09/2011 | CA2789073A1 Agent for preventing muscular atrophy |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218244 CREATINE ß-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218145 Antibodies to modified human igf-1/e peptides |
| 09/08/2011 | US20110218141 Leptin therapy to increase muscle mass and to treat muscle wasting conditions |
| 09/08/2011 | US20110217384 Modified Release Dosage Forms of Skeletal Muscle Relaxants |
| 09/08/2011 | US20110217303 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 09/08/2011 | US20110217287 Therapeutic composition comprising a botulinum neurotoxin |
| 09/08/2011 | US20110217278 Medication and Treatment for Disease |
| 09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
| 09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
| 09/07/2011 | CN1981744B Production of injection slow-releasing micropills of lycopodine and its derivative |
| 09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
| 09/07/2011 | CN102174048A Novel polymorphic form beta of soporifics |
| 09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
| 09/07/2011 | CN101597294B 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2011 | WO2011105572A1 Novel heteroaryl derivative |
| 09/01/2011 | US20110212995 Compositions and methods for treating spasticity |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212934 Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| 08/31/2011 | EP2183027B1 Organic compounds |
| 08/31/2011 | EP2020999B1 Compositions comprising alpha-ketoglutarate and their use for modulating muscle performance |
| 08/31/2011 | EP1270642B1 Branched polyalkylene glycols |
| 08/31/2011 | CN101810808B Chinese medicinal composition for treating tremor and preparation method thereof |
| 08/30/2011 | US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 08/30/2011 | US8008256 Disintegrin and microtubule stabilizing agent (small molecule cell division inhibitor); preventing metastasis |
| 08/30/2011 | US8007798 Treatment of complement-associated disorders |
| 08/30/2011 | CA2492021C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/30/2011 | CA2436407C Polymer conjugates of neublastin and methods of using same |
| 08/30/2011 | CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines |
| 08/25/2011 | WO2011102404A1 Imidazole derivative |
| 08/25/2011 | US20110207913 Induction of Gene Expression Using a High Concentration Sugar Mixture |
| 08/25/2011 | US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage |